(Q37374015)

English

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis

scientific article published on 21 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

1 reference

Europe PubMed Central

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

J Wouter Jukema

8

object named as

J Wouter Jukema

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Martin J. Schalij

7

object named as

Martin J Schalij

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sandrin C Bergheanu

2

object named as

Sandrin C Bergheanu

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Bas L van der Hoeven

4

object named as

Bas L van der Hoeven

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Josepha W M Plevier

6

object named as

Josepha W M Plevier

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Ayman K M Hassan

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Theo Stijnen

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Jaapjan D Snoep

5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

21 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1172-1180

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert [...]

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

What to do about late incomplete stent apposition?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Advanced methods in meta-analysis: multivariate approach and meta-regression.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Late incomplete stent apposition and focal vessel expansion after bare metal stenting.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Impact of late drug-eluting stent malapposition on 3-year clinical events.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Drug-eluting stents: caution and concerns for long-term outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Very late thrombosis after drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

The Delphi List

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN553

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHN553

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37374015&oldid=2103286039"